---
title: "XRAY.US (XRAY.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/XRAY.US/news.md"
symbol: "XRAY.US"
name: "XRAY.US"
parent: "https://longbridge.com/en/quote/XRAY.US.md"
datetime: "2026-05-20T14:36:08.543Z"
locales:
  - [en](https://longbridge.com/en/quote/XRAY.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/XRAY.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/XRAY.US/news.md)
---

# XRAY.US (XRAY.US) — Related News

### [Dentsply Sirona (XRAY) Narrower Q1 Loss Tests Bullish Margin Recovery Narrative](https://longbridge.com/en/news/285525967.md)
*2026-05-07T10:04:10.000Z*
> Dentsply Sirona (XRAY) reported Q1 2026 revenue of $880 million with a basic EPS loss of $0.05 and a net income loss of 

### [Dentsply Sirona Earnings Call Balances Progress and Pain](https://longbridge.com/en/news/285463352.md)
*2026-05-07T01:05:41.000Z*
> Dentsply Sirona's Q1 earnings call highlighted operational progress amid near-term challenges. Revenue remained flat at 

### [DENTSPLY SIRONA (XRAY) Receives a Sell from Citi](https://longbridge.com/en/news/285367306.md)
*2026-05-06T11:27:37.000Z*
> Citi analyst Daniel Grosslight has maintained a Sell rating on DENTSPLY SIRONA (XRAY) with a price target of $10.50. Thi

### [Dentsply Sirona Q1 2026 Earnings Call Transcript](https://longbridge.com/en/news/285274149.md)
*2026-05-05T21:42:36.000Z*
> Dentsply Sirona (NASDAQ:XRAY) reported its Q1 2026 earnings, focusing on sustainable growth initiatives and strategic pr

### [Dentsply Sirona | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 880 M](https://longbridge.com/en/news/285266786.md)
*2026-05-05T20:55:40.000Z*
### [Dentsply Sirona | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 880 M](https://longbridge.com/en/news/285262369.md)
*2026-05-05T20:32:20.000Z*